Silencing of Erbin, a tumor suppresser known to disrupt KSR1-RAF1 interaction, promoted cell migration and invasion of colon cancer cells, but did not identify the mechanism on how KSR1-dependent MAPK signaling affected EMT (Stevens et al., 2018). The gene discussed is ERBIN; the disease is neoplasm.